These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12131227)

  • 1. Triglyceride increase can predict lipodystrophy in HIV patients under highly active antiretroviral therapy.
    Rodriguez-Guardado A; Maradona JA; Carton JA; Asensi V
    AIDS; 2002 Jul; 16(10):1434-6. PubMed ID: 12131227
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV-associated asymmetric lipodystrophy syndrome.
    Quiros-Roldan E; Moretti F; Torti C; Casari S; Prestini K; Carosi G
    Rev Clin Esp; 2004 Mar; 204(3):177. PubMed ID: 15025990
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiretroviral treatment patterns and incident HIV-associated morphologic and lipid abnormalities in a population-based chort.
    Heath KV; Hogg RS; Singer J; Chan KJ; O'Shaughnessy MV; Montaner JS
    J Acquir Immune Defic Syndr; 2002 Aug; 30(4):440-7. PubMed ID: 12138351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-associated lipodystrophy, metabolic complications, and antiretroviral toxicities.
    Moyle G; Carr A
    HIV Clin Trials; 2002; 3(1):89-98. PubMed ID: 11894812
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-traditional adipokines in pediatric HIV-related lipodystrophy: a-FABP as a biomarker of central fat accumulation.
    Theodoridou K; Margeli A; Spoulou V; Bathrellou I; Skevaki C; Chrousos GP; Papassotiriou I; Kanaka-Gantenbein C
    Scand J Clin Lab Invest; 2014 Jan; 74(1):67-73. PubMed ID: 24266781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Switch" studies for people with lipodystrophy.
    Proj Inf Perspect; 2000 Aug; (30):9. PubMed ID: 12171017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic complications of HIV-1 antiretroviral therapy: the lipodystrophy syndrome.
    Borderi M; Verucchi G; Tadolini M; Spinosa S; Fortunato L; Talò S; Chiodo F
    New Microbiol; 2001 Jul; 24(3):303-15. PubMed ID: 11497090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shifty fat and bad bones (or, in vivo veritas).
    Mascolini M
    IAPAC Mon; 2000 Nov; 6(11):326-50. PubMed ID: 11299996
    [No Abstract]   [Full Text] [Related]  

  • 9. [Metabolic disorders and lipodystrophy. Adverse effects of antiretroviral therapy].
    Goebel FD; Westner I
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():40-4. PubMed ID: 11373778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switch therapy studies.
    Mallon PW
    J HIV Ther; 2001 May; 6(2):45-8. PubMed ID: 11505945
    [No Abstract]   [Full Text] [Related]  

  • 11. Highly active antiretroviral therapy and coronary heart disease: the need for perspective.
    Egger M; Junghans C; Friis-Møller N; Lundgren JD
    AIDS; 2001; 15 Suppl 5():S193-201. PubMed ID: 11816168
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of lipodystrophy in patients with human immunodeficiency virus infection].
    Paredes R; Muñoz J; Díaz I; Domingo P
    Med Clin (Barc); 2001 Mar; 116(12):469-75. PubMed ID: 11333708
    [No Abstract]   [Full Text] [Related]  

  • 13. Lipodystrophy and metabolic disorders as complication of antiretroviral therapy of HIV infection.
    Holstein A; Plaschke A; Egberts EH
    Exp Clin Endocrinol Diabetes; 2001; 109(8):389-92. PubMed ID: 11748485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CT appearances of HIV-related lipodystrophy syndrome.
    Gellett LR; Haddon L; Maskell GF
    Br J Radiol; 2001 Apr; 74(880):382-3. PubMed ID: 11387159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing patterns of morbidity and mortality in HIV disease.
    Calabrese LH
    Cleve Clin J Med; 2001 Feb; 68(2):105, 109-10, 112. PubMed ID: 11220453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipodystrophy syndrome in children infected with human immunodeficiency virus.
    Wedekind CA; Pugatch D
    Pharmacotherapy; 2001 Jul; 21(7):861-6. PubMed ID: 11444583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.
    Friis-Møller N; Weber R; Reiss P; Thiébaut R; Kirk O; d'Arminio Monforte A; Pradier C; Morfeldt L; Mateu S; Law M; El-Sadr W; De Wit S; Sabin CA; Phillips AN; Lundgren JD;
    AIDS; 2003 May; 17(8):1179-93. PubMed ID: 12819520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body habitus alterations in HIV-infected women treated with combined antiretroviral therapy.
    Ridolfo AL; Gervasoni C; Bini T; Galli M
    AIDS Patient Care STDS; 2000 Nov; 14(11):595-601. PubMed ID: 11155901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics of the lipodystrophy syndrome associated with HIV infection and combination antiretroviral therapy.
    Vidal F; Domingo P; Viladés C; Peraire J; Arnedo M; Alcamí J; Leal M; Villarroya F; Gatell JM
    Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1365-82. PubMed ID: 21999362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral therapy-induced lipodystrophy.
    Behera V; Randive M; Sundaray S; Murty MS
    BMJ Case Rep; 2015 Feb; 2015():. PubMed ID: 25678613
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.